Previous close | 4.4900 |
Open | 4.5100 |
Bid | 4.4900 x 1300 |
Ask | 4.5800 x 200 |
Day's range | 4.4801 - 4.7100 |
52-week range | 0.8010 - 9.6200 |
Volume | |
Avg. volume | 2,353,398 |
Market cap | 551.322M |
Beta (5Y monthly) | 1.51 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q4 2023 Earnings Call Transcript February 28, 2024 Mersana Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to the Mersana Therapeutics Fourth Quarter 2023 Conference Call and Webcast. Currently, all […]
Key Insights Mersana Therapeutics' estimated fair value is US$6.60 based on 2 Stage Free Cash Flow to Equity Mersana...
Mersana Therapeutics ( NASDAQ:MRSN ) Full Year 2023 Results Key Financial Results Revenue: US$36.9m (up 39% from FY...